Correspondence | Published:

The origins of new drugs


  • A Corrigendum to this article was published on 01 August 2005

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Cockburn, I. & Henderson, R. Public-Private Interaction and the Productivity of Pharmaceutical Research. National Bureau of Economic Research (NBER) Working Paper 6018 (NBER, Cambridge, MA, 1997).

  2. 2

    Powell, W.W., Korput, K.W. & Smith-Doerr, L. Administr. Sci. Quart. 41, 116–145 (1996).

  3. 3

    Murray, F. Res. Policy 31, 1389–1403 (2002).

  4. 4

    Henderson, R., Orsenigo, L. & Pisano, G.P. in Sources of Industrial Leadership, Studies of Seven Industries (eds. Mowery, D. & Nelson, R.) 267–311 (Cambridge University Press, Cambridge, UK, 1999).

  5. 5

    McKelvey, M. Evolutionary Innovations, the Business of Biotechnology (Oxford University Press, Oxford, 1996).

  6. 6

    Zucker, L.G. & Darby, M.R. Proc. Natl. Acad. Sci. USA 93, 12709–12716 (1996).

Download references

Author information

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

About this article

Further reading